Alpha Tau Medical annual return on equity
2022
2023
2024
2025
Alpha Tau Medical Return on Equity (ROE) Growth & History (DRTS)
Alpha Tau Medical's return on equity was −61.00% for fiscal 2025.
View full Alpha Tau Medical company overviewAlpha Tau Medical annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −61.00% | −17.84 pp |
| 2024 | 2024-12-31 | −43.16% | −12.49 pp |
| 2023 | 2023-12-31 | −30.67% | +64.59 pp |
| 2022 | 2022-12-31 | −95.27% | — |
Alpha Tau Medical quarterly return on equity
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −80.79% | −66.64 pp |
| Q1 2026 | 2026-03-31 | −31.33% | −16.72 pp |
| Q4 2025 | 2025-12-31 | −15.69% | — |
| Q3 2025 | 2025-09-30 | −14.23% | — |
| Q2 2025 | 2025-06-30 | −14.15% | — |
| Q1 2025 | 2025-03-31 | −14.61% | — |
Alpha Tau Medical return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Alpha Tau Medical's return on equity increased from −95.27% to −61.00%, a change of +34.27 percentage points. The latest reported quarter, Q2 2026, shows −80.79%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alpha Tau Medical source filings ↗